Tomaz, Paulo Roberto Xavier
Santos, Juliana Rocha
Scholz, Jaqueline
Abe, Tânia Ogawa
Gaya, Patrícia Viviane
Negrão, André Brooking
Krieger, José Eduardo
Pereira, Alexandre Costa
Santos, Paulo Caleb Júnior Lima
Article History
Received: 31 October 2016
Accepted: 23 March 2018
First Online: 5 April 2018
Ethics approval and consent to participate
: The study protocol was approved by the Ethics Committee for Medical Research on Human Beings of the Clinical Hospital of the University of São Paulo Medical School (SDC 4024/14/004). Signed informed consent will be obtained from all participants.
: Not applicable.
: The authors declare that they have no competing interests. JSI is the Principal Site Investigator in Varenicline Trials promoted by Pfizer.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.